A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen.

The objective was to investigate the stimulating and normalizing effect of the adaptogen Rhodiola rosea extract SHR-5 in foreign students during a stressful examination period. The study was performed as a double-blind, randomized and placebo-controlled with low repeated dose regime. The study drug and the placebo were taken for 20 days by the students during an examination period. The physical and mental performance were assessed before and after the period, based on objective as well as on subjective evaluation. The most significant improvement in the SHR-5 group was seen in physical fitness, mental fatigue and neuro-motoric tests (p <0.01). The self-assessment of the general well-being was also significantly (p < 0.05) better in the verum group. No significance was seen in the correction of text tests or a neuro-muscular tapping test. The overall conclusion is that the study drug gave significant results compared to the placebo group but that the dose level probably was suboptimal.

[The effect of the preparation rodakson on the psychophysiological and physical adaptation of students to an academic load]. / Vliianie preparata rodakson na psikhofiziologicheskuiu i fizicheskuiu adaptatsiiu studentov k uchebnoi nagruzke.

The effect of rhodaxon, an adaptogen preparation based on the Rhodiola rosea extract, upon the physical and intellectual working capacity and psychoemotional state of foreign students during their study in a Russian high school was evaluated. It was established that rhodaxon administration provided increase in the amount of veloergometric work accomplished and reliably increased the kinesthesiometric sensitivity. The drug also lead to marked increased in the general condition and a decrease in the level of psychic fatigue and situational anxiety. On the whole, the pharmacological properties of the rhodaxon preparation studied coincided with those reported for the gold root extract. The fact that the rhodaxon preparation contains no ethyl alcohol extends possibilities of the clinical administration of the new preparation.